Venture&Growth
Location
Dublin, Ireland
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Irish MedTech company focused on remote monitoring of heart failure patients.
FIRE1 is a connected medical device solutions company dedicated to improving outcomes for people suffering from chronic diseases. Its first product is a novel remote monitoring solution for heart failure patients. FIRE1 is led by an experienced medical devices team who are working closely with researchers, clinicians, patients and payors to help reduce the burden of heart failure.
More Fire1 news
Gilde Healthcare company FIRE1 raises $25 million to revolutionize heart failure home monitoring
Gilde Healthcare leads EUR 40 Million financing in Irish healthtech company FIRE1
Venture&Growth
ADCendo
Danish Therapeutics company focused on antibody-drug conjugates (ADCs) for the treatment of cancers.
Venture&Growth
Tagworks
Tagworks Pharmaceuticals is a privately held therapeutics company based in the Netherlands. It leverages unique technologies to increase efficacy and decrease toxicity across multiple systemic treatment modalities. The company has pioneered a unique and proprietary Click-to-Release drug development technology, enabling
Venture&Growth
SynOx Therapeutics
SynOx Therapeutics Limited is a Dublin-based, late clinical-stage biopharmaceutical company developing emactuzumab, a best-in-class monoclonal antibody against CSF-1R, for the treatment of Tenosynovial Giant Cell Tumour (TGCT) and other CSF-1 related and macrophage driven disorders. TGCT is a rare, non-malignant but
